AIM AIM ImmunoTech Inc.
$0.24▲ +1.69%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$6.65M
P/E Ratio
–
Div Yield
–%
52W Range
0.21 - 3.29
% vs 50 MA
-33.85%
% vs 200 MA
-75.22%
RSI-14
35.3
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.41
Gross Rev
$88,000
Gross Profit
-$40,000
EBITDA
-$11.45M
COGS
$128,000
Operating Exp
$11.41M
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Jun 2026 (Quarterly)
Social Sentiment
Avg +0.56 · 64 posts
NewsBlue Origin Raising First Outside Capital, Seeking $10B at a $130B Valuation
r/StockMarket · Jul 8, 2026
positive
+0.40
DiscussionNewsOracle power Plc
r/stocks · Jul 1, 2026
The post discusses the company's market listing and projects positively related to this listing.
positive
+0.60
NewsDiscussionOuster hits all time high after AIM deal and robotics demand surge
r/stocks · Jun 29, 2026
The partnership is a positive development for both companies and the discussed application of Ouster’s sensors.
positive
+0.60
DiscussionNvidia debuts RTX Spark processor for Windows laptops, taking aim at Intel, AMD
r/StockMarket · Jun 1, 2026
The post frames AMD as a competitor to RTX, suggesting a topic of interest within the broader semiconductor landscape.
positive
+0.60
DiscussionNeed investment tracking app with TWR (Allinvestview?)
r/investing · May 11, 2026
The post is discussing a portfolio tracking app and the use of TWR, and refers to AllInvestview as the focus.
positive
+0.60
Page 1 of 13 (64 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.